Simvastatin combined with aspirin increases the survival time of heart allograft by activating CD4+CD25+ Treg cells and enhancing vascular endothelial cell protection-Reference-Cited by-同舟云学术

Simvastatin combined with aspirin increases the survival time of heart allograft by activating CD4+CD25+ Treg cells and enhancing vascular endothelial cell protection

Published:2015-05 Issue:3 Volume:24 Page:173-178
ISSN:1054-8807
Container-title:Cardiovascular Pathology
language:en
Short-container-title:Cardiovascular Pathology

Author:

Zhu Jinguo,Gao Bingren

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Pathology and Forensic Medicine

Reference22 articles.

1. Cardiac allograft rejection;Patel;Surgeon,2011

2. Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats;Sun;Transpl Immunol,2012

3. Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice;Guo;Transpl Immunol,2013

4. The 2013 International Society for Heart and Lung Transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation;Berry;J Heart Lung Transplant,2013

5. Improved technique of heart transplantation in rats;Ono;J Thorac Cardiovasc Surg,1969

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting regulatory T cells for cardiovascular diseases;Frontiers in Immunology;2023-02-23

2. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis;The Journal of Heart and Lung Transplantation;2023-01

3. Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?;Liver Transplantation;2022-08-23

4. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism;International Immunopharmacology;2021-02

5. Micro‐ and macrovascular cardiac allograft vasculopathy in relation to 91 cardiovascular biomarkers in heart transplant recipients—An exploratory study;Clinical Transplantation;2020-11-20